Statements of Shareholders' Deficiency - USD ($)	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock, shares outstanding, beginning balance (in shares)	1,233,853
Shareholders' deficiency, beginning balance	$ (930,624)	$ (835,505)
Net loss	$ (103,388)	$ (95,119)
Common stock, shares outstanding, ending balance (in shares)	1,233,853	1,233,853
Shareholders' deficiency, ending balance	$ (1,034,012)	$ (930,624)
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock, shares outstanding, beginning balance (in shares)	1,233,853	1,233,853
Shareholders' deficiency, beginning balance	$ 1,233	$ 1,233
Common stock, shares outstanding, ending balance (in shares)	1,233,853	1,233,853
Shareholders' deficiency, ending balance	$ 1,233	$ 1,233
Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shareholders' deficiency, beginning balance	81,323	81,323
Shareholders' deficiency, ending balance	81,323	81,323
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shareholders' deficiency, beginning balance	(1,013,180)	(918,061)
Net loss	(103,388)	(95,119)
Shareholders' deficiency, ending balance	$ (1,116,568)	$ (1,013,180)